2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Risk Tolerance of Therapeutic Interventions in People with Parkinson’s Disease

B. Dukes, A. Colombo, K. Patel, D. Shah-Zamora (Winston Salem, USA)
Role of RNA splicing in Parkinson’s disease

K. Irmady, C. Hale, R. Qadri, J. Fak, T. Carroll, R. Darnell (New York, USA)
Role of Telemedicine- Versus Outpatient-Based Initiation And Management of Atkins Diet Therapy In Postmenopausal Women With Drug-Resistant Parkinson’s Disease During The COVID-19 Pandemic

M. Sharma, S. Sinha (Pimpri, India)
Role of the Alpha-synuclein Seed Amplification Assay in Parkinson’s Disease Clinical Trials: A Case Report of Multiple System Atrophy Misdiagnosed as Parkinson’s Disease

E. Tharp, J. Martinez-Lemus, J. Suescun, C. Adams, M. Shahnawaz, T. Ellmore, M. Schiess (Houston, USA)
Role of Wearable Devices in a Physical Activity Coaching Program for People with Parkinson Disease

A. Pacheco, K. Long, D. Wani, J. Alomar, D. Kipnis, C. Macpherson (NYC, USA)
Rora deficiency aggravates dopamine neurons loss via reducing NAD+ level in Parkinson’s disease

JW. Li, HS. Liu, XY. Hu, T. Wang, N. Xiong (Wuhan, China)
Rural Tanzania’s Wide “PD Gap” Through the Decades

M. Dekker, S. Urasa, W. Howlett, R. Morton, J. Josephat, R. Walker (Moshi, United Republic of Tanzania)
Safety and effectiveness of staged bilateral MR-guided focused ultrasound pallidothalamic tractotomy for motor complications of Parkinson’s disease: study protocol

A. Dalvi, L. Zucker, WC. Chang, PH. Wu, M. Kaplitt, H. Sarva, HM. Eisenberg, P. Fishman, V. Buch, M. Matarazzo, M. Del Alamo, S. Sani, M. Pourfar, A. Mogilner (West Palm Beach, USA)
Safety and efficacy of bilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy for refractory essential tremor.

D. Vilas, L. Ispierto, M. Tardáguila, J. Muñoz, A. González, JA. Pérez, R. García, R. álvarez (Badalona, Spain)
Safety and Efficacy of Sublingual Apomorphine in Parkinson’s Patients with or without Concomitant Dopamine Agonists Use

D. Santos Garcia, W. Jost, M. José Martí, M. Fonseca, C. Denecke Muhr, I. Pijuan (A Coruña, Spain)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z